Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Amphastar Pharmaceuticals, Inc. (AMPH : NSDQ)
 
 • Company Description   
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Number of Employees: 2,028

 
 • Price / Volume Information   
Yesterday's Closing Price: $26.78 Daily Weekly Monthly
20 Day Moving Average: 329,938 shares
Shares Outstanding: 45.95 (millions)
Market Capitalization: $1,230.60 (millions)
Beta: 0.89
52 Week High: $39.01
52 Week Low: $20.39
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.36% -1.20%
12 Week 7.25% 5.52%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11570 SIXTH STREET
-
RANCHO CUCAMONGA,CA 91730
USA		 ph: 909-980-9484
fax: 909-980-8296		 jasons@amphastar.com http://www.amphastar.com
 
 • General Corporate Information   
Officers
Jack Yongfeng Zhang - Chief Executive Officer and President
Mary Z. Luo - Chairman and Chief Operating Officer
William J. Peters - Chief Financial Officer
Jacob Liawatidewi - Executive Vice President
Gayle M. Deflin - Director

Peer Information
Amphastar Pharmaceuticals, Inc. (BGMR)
Amphastar Pharmaceuticals, Inc. (BBIO)
Amphastar Pharmaceuticals, Inc. (IPAH)
Amphastar Pharmaceuticals, Inc. (BRL)
Amphastar Pharmaceuticals, Inc. (BHC)
Amphastar Pharmaceuticals, Inc. (AKRXQ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 03209R103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/26/26
Share - Related Items
Shares Outstanding: 45.95
Most Recent Split Date: (:1)
Beta: 0.89
Market Capitalization: $1,230.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.91 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.32 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 1.11% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/26/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 8.07
Trailing 12 Months: 8.87
PEG Ratio: 7.27
Price Ratios
Price/Book: 1.60
Price/Cash Flow: 5.35
Price / Sales: 1.70
EPS Growth
vs. Year Ago Period: -4.60%
vs. Previous Quarter: 10.67%
Sales Growth
vs. Year Ago Period: 0.33%
vs. Previous Quarter: 9.99%
ROE
12/31/25 - -
09/30/25 - 19.70
06/30/25 - 20.76
ROA
12/31/25 - -
09/30/25 - 9.17
06/30/25 - 9.68
Current Ratio
12/31/25 - -
09/30/25 - 3.12
06/30/25 - 3.29
Quick Ratio
12/31/25 - -
09/30/25 - 2.21
06/30/25 - 2.21
Operating Margin
12/31/25 - -
09/30/25 - 20.55
06/30/25 - 21.32
Net Margin
12/31/25 - -
09/30/25 - 15.43
06/30/25 - 18.64
Pre-Tax Margin
12/31/25 - -
09/30/25 - 18.76
06/30/25 - 22.40
Book Value
12/31/25 - -
09/30/25 - 16.71
06/30/25 - 16.07
Inventory Turnover
12/31/25 - -
09/30/25 - 2.04
06/30/25 - 2.19
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.78
06/30/25 - 0.80
Debt-to-Capital
12/31/25 - -
09/30/25 - 43.93
06/30/25 - 44.51
 

Powered by Zacks Investment Research ©